台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

(TSD-3) How to optimize evaluation of renal transplant recipient to prevent antibody-mediated rejection_盧嘉文

2023-02-13 • 觀看: 5 • 回應: 0 • 影片
(TSD-2) Experience of ABO-incompatible kidney transplantation in transplant team of CMUH_蕭博任

2023-02-13 • 觀看: 4 • 回應: 0 • 影片
(TSD-1) Update of protocol about preparation and care of HLA positive and ABO incompatible kidney transplantation_王碩盟

2023-02-13 • 觀看: 4 • 回應: 0 • 影片
(TSC-2) Front line treatment for metastatic renal cell carcinoma: an update_魏子鈞

2023-02-13 • 觀看: 18 • 回應: 0 • 影片
(TSC-1) Updates of adjuvant therapy in renal cell carcinoma_洪健華

2023-02-13 • 觀看: 13 • 回應: 0 • 影片
(TSB-2) Advanced prostate cancer 2022 update_虞凱傑

2023-02-13 • 觀看: 25 • 回應: 0 • 影片
(TSB-1) Epigenetic regulation of lineage plasticity and anti-androgen resistance in neuroendocrine prostate cancer (NEPC)_張佩靖

2023-02-13 • 觀看: 13 • 回應: 0 • 影片
(TSA-2) Biomarkers in urothelial carcinoma_王紹全

2023-02-13 • 觀看: 15 • 回應: 0 • 影片
(TSA-1) Perioperative treatment for high risk urothelial carcinoma_李建儀

2023-02-13 • 觀看: 27 • 回應: 0 • 影片
(ME2-1) Molecular mechanisms of microenergy acoustic pulse (MAP) therapy in tissue regeneration_Tom Lue

2023-02-13 • 觀看: 13 • 回應: 0 • 影片
(LS1-2) New development of HIFU therapy for patients in our hospital_虞凱傑

2023-02-13 • 觀看: 28 • 回應: 0 • 影片
(LS1-1) Clinical study of focal therapy with HIFU based on the MRI-TRUS fusion image-guided prostate biopsy in Japan_Sunao Shoji

2023-02-13 • 觀看: 26 • 回應: 0 • 影片

Prev
492
493
494
495
496
497
498
499
500
501
Next
/ 1264